Early postnatal gentamicin and ceftazidime treatment in normal and food restricted neonatal wistar rats: Implications for kidney development. Issue 15 (11th July 2017)

• Record Type: Journal Article
• Authors: Bueters, Ruud R.G.; Jeronimus‐Klaasen, Annelies; Brüggemann, Roger J.M.; van den Heuvel, Lambertus P.; Schreuder, Michiel F.
• Is Part Of: Birth defects research. Volume 109:Issue 15(2017)
• Page Start: 1228
• Page End: 1235
• Publication Date: 2017-07-11
• Subjects: gentamicin -- nephrogenesis -- ceftazidime -- stereology -- kidney -- development -- extrauterine growth restriction; Teratology -- Periodicals; Abnormalities, Human -- Periodicals; Congenital Abnormalities; Embryo, Mammalian -- abnormalities; Teratology; Abnormalities, Human; Teratology; Periodicals; Periodicals; 616.043
• DOI: 10.1002/bdr2.1071
• Languages: English
• ISSNs: 2472-1727

Abstract

Abstract : Background: Up to two‐thirds of premature born neonates are treated for infections with aminoglycosides such as gentamicin. Although acute toxicities are well described, there is uncertainty on developmental changes after treatment of premature born neonates. We studied the effect of gentamicin and ceftazidime on kidney development in the rat. Additionally, we evaluated the modulating effect of extrauterine growth restriction. Methods: On postnatal day (PND) 2, Wistar rats were cross‐fostered into normal sized litters (12 pups) or large litters (20 pups) to create normal food (NF) or food restricted (FR) litters to simulate growth restriction and dosed daily intraperitoneally with placebo, 4 mg/kg of gentamicin or 50 mg/kg ceftazidime until PND 8. Gentamicin pharmacokinetics were studied in a separate group of animals. Kidneys were weighed. Renal expression of 18 developmental genes was evaluated by quantitative PCR on PND 8. On PND 35, glomerular number was assessed by stereology and glomerular generations were counted. Results: Food restricted litters showed 22% less body weight compared with controls by day 35 ( p < 0.001), 1.4‐ to 1.5‐fold down regulation of Renin, Oat1, and Agtr1a ( p < 0.05) expression and a 12% reduction in glomerular numbers (mean 30841 vs. 35187, p < 0.001), whereas glomerular generation count was unaffected. Gentamicin pharmacokinetic parameters were found to be in a human clinical range (mean maximum concentration in plasma of 4.88 mg/L and mean area under the plasma‐concentration time curve up to the last measured concentration after 4 hr of 10.71 mg.h/L for sexes combined) and all endpoints were unaffected. Ceftazidime reduced Renin expression by 1.7‐fold ( p < 0.01). Conclusion: Our experiments showed that gentamicin at clinical levels did not disturb kidney development, ceftazidime can affect Renin expression, and extrauterine growth restriction impairs kidney development, but did not modulate potential drug toxicity. Birth Defects Research 109:1228–1235, 2017. © 2017 Wiley Periodicals, Inc.